Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction

@article{Waldo1996EffectOD,
  title={Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction},
  author={Albert L. Waldo and A John Camm and H A Deruyter and Peter L. Friedman and Daniel J. MacNeil and John F. Pauls and Bertram Pitt and Craig M. Pratt and Peter J. Schwartz and Enrico P. Veltri},
  journal={The Lancet},
  year={1996},
  volume={348},
  pages={7-12}
}
Effect of relatively low dose amiodarone therapy on left ventricular function in patients with ventricular tachyarrhythmias.
TLDR
oral AMD therapy did not cause LV function to recover significantly and could not improve the clinical course in patients with ventricular tachyarrhythmias, however, if the underlying disease is not progressive, AMD therapy may improve LV function.
Mortality in Patients After a Recent Myocardial Infarction: A Randomized, Placebo-Controlled Trial of Azimilide Using Heart Rate Variability for Risk Stratification
TLDR
Low HRV independently identified a subpopulation at high risk of mortality after myocardial infarction and azimilide did not improve or worsen the mortality of patients after MI.
Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.
TLDR
In patients with congestive heart failure and reduced left ventricular function, dofetilide was effective in converting atrial fibrillation, preventing its recurrence, and reducing the risk of hospitalization for worsening heart failure.
Effect of pimobendan in patients with chronic heart failure.
TLDR
Pimobendan is effective in patients with chronic heart failure but is less effective in Patients with OMI than in patientswith DCM or other heart diseases.
...
...

References

SHOWING 1-10 OF 41 REFERENCES
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.
TLDR
The angiotensin-converting--enzyme inhibitor enalapril significantly reduced the incidence of heart failure and the rate of related hospitalizations, as compared with the rates in the group given placebo, among patients with asymptomatic left ventricular dysfunction.
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.
TLDR
In patients with asymptomatic left ventricular dysfunction after myocardial infarction, long-term administration of captopril was associated with an improvement in survival and reduced morbidity and mortality due to major cardiovascular events.
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.
TLDR
The addition of enalapril to conventional therapy significantly reduced mortality and hospitalizations for heart failure in patients with chronic congestive heart failure and reduced ejection fractions.
Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.
TLDR
It is concluded that neither encainide nor flecainide should be used in the treatment of patients with asymptomatic or minimally symptomatic ventricular arrhythmia after myocardial infarction, even though these drugs may be effective initially in suppressing ventricular arrhythmia.
Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.
TLDR
Although amiodarone was effective in suppressing ventricular arrhythmias and improving ventricular function, it did not reduce the incidence of sudden death or prolong survival among patients with heart failure, except for a trend toward reduced mortality among those with nonischemic cardiomyopathy.
...
...